Biotechnology Palatin Technologies Eyes Growing $6B Dry Eye Disease Market With Late-Stage Study Data Why Is Palatin Technologies Stock Soaring On Monday? – Palatin Techs (AMEX:PTN) Read more
Biotechnology Relief For Dry Eye Disease? OKYO Pharma’s Candidate Shows Durable Pain Relief In Mid-Stage Study – OKYO Pharma (NASDAQ:OKYO) Read more
Stockmarkets Japan’s Asahi eyes overseas M&A to quadruple sales of Super Dry beer Reuters via biedexmarkets.com Read more
Stockmarkets United Maritime transitions to dry bulk, posts Q4 results By biedexmarkets.com Read more